Ben Paterson
Asia-Pacific Guide 2024
Band 3 : Corporate/Commercial
Share profile
Band 3
About
Provided by Ben Paterson
Practice Areas
Ben is a key dealmaker for Russell McVeagh, with expertise in mergers and acquisitions, private equity transactions, joint ventures and overseas investment. Ben has acted on a number of significant and complex financial transactions, providing high quality legal advice to large scale, high-profile private equity and corporate clients, including Pacific Equity Partners, CPE Capital, Carlyle, The Riverside Company, Fonterra and Lion. He is one of New Zealand's leading experts on the NZ foreign direct investment regime and has been heavily involved in significant changes to the regime as well as providing advice to off-shore clients. He recently advised Fonterra on its $552 million sale of its dairy farms in China and its $633 million sale of DFE Pharma to CVC, and Advent International on its acquisition (through its portfolio company Industria Chimica Emiliana) of New Zealand Pharmaceuticals.
Career
Ben joined Russell McVeagh in 2008 and progressed to partner in 2017.
Professional Memberships
Ben is a member of the New Zealand Private Capital Association and the Australian New Zealand Sports Law Association.
Publications
Ben is a regular contributor to Russell McVeagh's thought leadership on foreign investment and M&A, and has recently co-authored the New Zealand chapter of the Chambers and Partners 2021 Private Equity Guide.
Chambers Review
Asia-Pacific
Ben Paterson frequently advises in relation to private equity transactions and is also active with regard to public M&A deals. He is based in Auckland.
Contributions
Latest contributions provided by Ben Paterson
Strengths
Provided by Chambers
"Ben is deeply methodical and walks us through the issues step by step."
"Ben is deeply methodical and walks us through the issues step by step."
Discover other Lawyers at
Russell McVeagh
New Zealand
